First genomic insights into multidrug-resistant Staphylococcus pseudintermedius from dogs in Vietnam
Comparative Immunology, Microbiology and Infectious Diseases · 2026-07 · 128 · 102489
DOI: 10.1016/j.cimid.2026.102489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Immunology, Microbiology and Infectious Diseases, 2026-07. Verfasst von Nguyen Thi Lan Anh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, HUTECH University, Thanh My Tay Ward, Ho Chi Minh City, Viet Nam. Hauptthemen laut MEDLINE: Staphylococcus, Drug Resistance, Multiple, Bacterial, Dog Diseases, Staphylococcal Infections. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Staphylococci are commensal and opportunistic bacteria in humans and animals. The emergence of multidrug-resistant (MDR) staphylococci poses a growing threat to both veterinary and public health worldwide. In this study, two MDR Staphylococcus pseudintermedius (S. pseudintermedius) isolates, RB10.2 and SB24, obtained from diseased dogs in Vietnam, were subjected to draft whole-genome sequencing and comparative genomic analysis. Draft genome sizes ranged from 2635,269 bp (SB24) to 2670,853 bp (RB10.2), with an average GC content of approximately 37.35%. Each genome contained more than 23 antibiotic resistance genes. Additionally, 20 virulence genes were identified, including those encoding intercellular adhesin, lipase, thermonuclease, adenosine synthase A, capsular polysaccharide synthesis, enterotoxins A and C, leukotoxins D and E, and lipoproteins involved in host cell entry and diacylglyceryl transferase. Multilocus sequence typing based on the PubMLST database identified RB10.2 as sequence type (ST) 733, while SB24 represented a novel ST, designated ST2738. A minimal spanning tree constructed from 781 publicly available S. pseudintermedius genomes revealed that ST733 (RB10.2) is closely related to ST551, while the novel ST2738 (SB24) is genetically linked to ST755. Both isolates showed phylogenetic relatedness to strains of canine and human origin. This study provides the first genomic insights into MDR S. pseudintermedius from dogs in Vietnam and highlights the emergence of novel genetic lineages. Continued surveillance is warranted to monitor the evolution and dissemination of these lineages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, HUTECH University, Thanh My Tay Ward, Ho Chi Minh City, Viet Nam.
- Faculty of Veterinary Medicine, College of Agriculture, Can Tho University, Ninh Kieu ward, Can Tho City, Viet Nam.
- School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
- Faculty of Veterinary Medicine, College of Agriculture, Can Tho University, Ninh Kieu ward, Can Tho City, Viet Nam. Electronic address: ntlam@ctu.edu.vn.
Zitieren
APA
Thi Lan Anh, N., Thi Thanh Hang, L., Thi Kim Cuc, D., Thuy Y Vi, N., Tran, D. H., Tien, P. P. M., Hemmatzadeh, F., & Nguyen, L. T. (2026). First genomic insights into multidrug-resistant Staphylococcus pseudintermedius from dogs in Vietnam. Comparative Immunology, Microbiology and Infectious Diseases, 128, 102489. https://doi.org/10.1016/j.cimid.2026.102489
Vancouver
Thi Lan Anh N, Thi Thanh Hang L, Thi Kim Cuc D, Thuy Y Vi N, Tran DH, Tien PPM, et al. First genomic insights into multidrug-resistant Staphylococcus pseudintermedius from dogs in Vietnam. Comparative Immunology, Microbiology and Infectious Diseases. 2026;128:102489. doi:10.1016/j.cimid.2026.102489
BibTeX
@article{ThiLanAnh2026,
author = {Thi Lan Anh, Nguyen and Thi Thanh Hang, Luu and Thi Kim Cuc, Doan and Thuy Y Vi, Nguyen and Tran, Dao Huyen and Tien, Pham Phan My and Hemmatzadeh, Farhid and Nguyen, Lam Thanh},
title = {First genomic insights into multidrug-resistant Staphylococcus pseudintermedius from dogs in Vietnam},
journal = {Comparative Immunology, Microbiology and Infectious Diseases},
year = {2026},
volume = {128},
pages = {102489},
doi = {10.1016/j.cimid.2026.102489}
}
EUVIMED